| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 143.48M | — |
| Operating expense | — | — |
| Net income | -46.65M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, EVO returned -47.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -38.3% |
| 1 year | -47.8% |
| 5 years | -92.4% |
| 10 years | -23.2% |
| All-time high | $25.01 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in EVO would be worth today ›No. Evotec SE has not paid a dividend in the past 12 months.
Evotec SE stock trades on NASDAQ under the ticker symbol EVO.
Evotec SE is part of the Healthcare sector.
Evotec SE has a market cap of 675.24M USD, based on the latest quote.
Evotec SE is scheduled to report earnings on Nov 5, 2026.
